SS Innovations International, Inc SSII 深 沪
等待开盘 06-26 09:30:00 美东时间
3.58
+0.060
+1.70%
华盛通- 最 高3.75
- 今 开3.52
- 成交量 3.66万股
- 最 低 3.22
- 昨 收 3.52
- 总市值 0
- 52周最高 10.00
- 市盈率 静 --
- 换手率 Infinity.00%
- 52周最低 3.11
- 委 比 -77.36%
- 总股本 --
- 历史最高 22.42
- 量 比 0
- 振 幅 15.06%
- 历史最低 3.015
- 每 手 1
- 风险率 1.43%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多SS Innovations Completes World's Longest-Distance Robotic Telesurgery Between Guyana And India
SS Innovations International, Inc. (the "Company" or "SS Innovations") (NASDAQ:SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global
06-04 20:40
SS Innovations International Files Prospectus For Offering 11.3M Common Shares
SEC Filing.
02-02 21:26
黯然离场！西南证券控股孙公司西证国际证券将退市
炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 9月15日，港股券商西证国际证券（00812）发布公告称，已收到联交所上市委员会...
2025-09-16 11:46
SS Innovations Announces Successful Completion of First Robotic Cardiac Surgery in the Western Hemisphere Utilizing the Company’s SSi Mantra 3 Surgical Robotic System
Dr. Juan Zuniga successfully performed the first robotic cardiac surgery in the Americas and Western Hemisphere using SS Innovations' SSi Mantra 3 system in Ecuador. The procedure, an atrial septal defect closure, was completed effectively, showcasing faster recovery and precision, with the patient recovering well.
2025-06-16 12:45
SS Innovations to Ring the Nasdaq Opening Bell on Tuesday, June 3, 2025
SS Innovations International,Inc. will ring the opening bell at the Nasdaq MarketSite on June 3,2025, celebrating its stock uplisting and the successful completion of over 4,000 robotic surgeries with its SSi Mantra system. The company aims to expand its reach globally, including Europe and the U.S., to make robotic surgery more accessible and affordable.
2025-06-02 12:30
SS Innovations Surpasses Milestone of 4,000 Robotic Surgeries Successfully Performed with the SSi Mantra Surgical Robotic System
SS Innovations' SSi Mantra robotic surgical system has successfully performed over 4,000 surgeries across 100 types, including 215 cardiac procedures with six tele surgeries in India. The system is approved in seven countries, targeting expansion in the U.S. and EU, with potential FDA and CE approval by mid-2026 and late 2025 respectively.
2025-05-27 12:30
